Article Type

1 - 15 of 27 Results       Clear All

A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys

Gladstone in the News June 27, 2020

A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys

The New York Times—Gladstone President Deepak Srivastava, MD, and Senior Investigator Jennifer Doudna, PhD, comment on a recent report of the successful use of novel CRISPR technology to lower cholesterol and triglyceride levels in monkeys.

Gladstone Experts Heart Failure Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing Disease Models

Gladstone Institutes Researchers Tackle Coronavirus with Robotics, Mobile Phone Technology

Gladstone in the News April 30, 2020

Gladstone Institutes Researchers Tackle Coronavirus with Robotics, Mobile Phone Technology

Engineering.com—Gladstone Senior Investigators Melanie Ott and Jennifer Doudna are collaborating with scientists across the Bay Area to develop a rapid COVID-19 testing platform that pairs CRISPR technology with a smartphone camera.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab CRISPR/Gene Editing

Connecting the Dots: From Stem Cells to Human Health

Illustration of stem cells
Article October 9, 2019

Connecting the Dots: From Stem Cells to Human Health

Since Shinya Yamanaka discovered a method to create human induced pluripotent stem cells (hiPS cells), Gladstone researchers have built on this technology to create numerous iPS cell lines, coax iPS cells into a myriad of tissue types, use them as a tool to study disease, and even begin creating therapies using these cells.

Research (Publication) Finkbeiner Lab Huang Lab McDevitt Lab Srivastava Lab Yamanaka Lab CRISPR/Gene Editing Stem Cells/iPSCs

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media